- Home
- / Optibiotix Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Optibiotix Health financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
£0.1
2024-10-29
Market Capitalization
£11.3 M
2024-10-29
Revenue
£870 K
FY, 2024
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 514.0K | 745.0K | 1.5M | 2.2M | 457.0K | 644.0K | 870.0K |
| Cost of goods sold | 163.0K | 352.0K | 643.0K | 1.1M | 213.0K | 324.0K | 539.0K |
| Gross profit | 351.0K | 393.0K | 880.0K | 1.1M | 244.0K | 424.0K | 331.0K |
| Gross profit margin, % | 68.3% | 52.8% | 57.8% | 50.7% | 53.4% | 65.8% | 38.0% |
| Operating expense total | 1.7M | 2.1M | 1.6M | 1.1M | 1.8M | 1.6M | 2.6M |
| Depreciation and amortization | 142.0K | 218.0K | 249.0K | 288.0K | 224.0K | 205.0K | |
| EBITDA | (1.8M) | (2.0M) | 3.1M | 69.0K | (9.6M) | (1.5M) | (2.6M) |
| EBITDA margin, % | -351.2% | -268.2% | 204.7% | 3.1% | -2108.1% | -231.4% | -300.7% |
| EBIT | (1.9M) | (2.2M) | 2.9M | (219.0K) | 11.8M | (1.7M) | (2.6M) |
| EBIT margin, % | -378.8% | -297.4% | 188.4% | -9.9% | 2583.2% | -263.2% | -300.7% |
| Interest income | 1.0K | ||||||
| Interest expense | 44.0K | 44.0K | 48.0K | 1.0K | |||
| Pre tax profit | (1.9M) | (2.2M) | 5.7M | 6.2M | 2.4M | (2.0M) | (1.9M) |
| Income tax expense | (54.0K) | (123.0K) | (92.0K) | (85.0K) | (146.0K) | (4.0K) | (61.0K) |
| Net Income | (1.9M) | (2.1M) | 5.8M | 6.3M | 2.6M | (2.0M) | (1.8M) |